SINT Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

3.288

Open

3.260

VWAP

3.00

Vol

80.00K

Mkt Cap

12.00M

Low

3.120

Amount

259.00K

EV/EBITDA(TTM)

--

Total Shares

4.00M

EV

7.00M

EV/OCF(TTM)

--

P/S(TTM)

6.00

SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.

Show More

Events Timeline

(ET)

2025-12-01

08:41:00

SINTX Signs Supply Agreement with Evonik to Accelerate Patient-Specific Implant Production

2025-11-13 (ET)

2025-11-13

08:05:02

Sintx Technologies Announces Q3 EPS of $3.46 Compared to $6.96 Last Year

2025-11-03 (ET)

2025-11-03

08:03:38

Sintx Technologies unveils OsseoSculpt launch

2025-10-23 (ET)

2025-10-23

16:35:12

Sintx Technologies seeks approval to sell 1.74 million shares of common stock for its shareholders.

2025-10-20 (ET)

2025-10-20

07:03:08

Sintx Secures FDA Approval for SINAPTIC Foot and Ankle Implant System

2025-10-14 (ET)

2025-10-14

07:06:28

Sintx Technologies Receives Notice of Allowance for U.S. Patent

2025-09-08 (ET)

2025-09-08

07:57:10

Sintx Technologies Reveals $3.8M Gross Proceeds from Warrant Exercise

2025-09-08

07:21:52

Sintx Technologies Granted Notice of Allowance by USPTO

2025-09-03 (ET)

2025-09-03

07:09:29

Sintx Technologies Releases Research on the Antiviral Properties of Silicon Nitride

2025-08-15 (ET)

2025-08-15

07:05:14

Sintx Technologies issues business update following strategic realignment

News

an image of Globenewswire

2025-12-08Globenewswire

SINTX Technologies to Present at Sidoti Year End Virtual Investor Conference

an image of Newsfilter

2025-12-08Newsfilter

SINTX Technologies to Present at Sidoti's Year End Virtual Investor Conference

an image of Newsfilter

2025-10-20Newsfilter

SINTX Technologies Obtains FDA Approval for SINAPTIC® Foot and Ankle Implant System

an image of NASDAQ.COM

2025-10-16NASDAQ.COM

Reasons to Consider SINTX TECHNOLOGIES, INC. (SINT) as a Strong Momentum Stock: Is It Time to Buy?

an image of Benzinga

2025-09-22Benzinga

Ascendiant Capital Reaffirms Buy Rating on SINTX Technologies, Adjusts Price Target to $25

an image of TipRanks

2025-09-08TipRanks

Monday's Major Stock Market Highlights: Morning News Summary!

1 Analyst Rating

Wall Street analysts forecast SINT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SINT is 16.00 USD with a low forecast of 16.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

16.00

Averages

16.00

High

16.00

Current: 0.000

Low

16.00

Averages

16.00

High

16.00

Ascendiant Capital

Edward Woo

Strong Buy

Maintains

$70 → $30

AI Analysis

2025-04-21

Reason

Ascendiant Capital

Edward Woo

Price Target

$70 → $30

AI Analysis

2025-04-21

Maintains

Strong Buy

Reason

Valuation Metrics

The current forward P/E ratio for SINTX Technologies Inc (SINT.O) is -1.73, compared to its 5-year average forward P/E of -16.95. For a more detailed relative valuation and DCF analysis to assess SINTX Technologies Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PE

-16.95

Current PE

-1.73

Overvalued PE

55.43

Undervalued PE

-89.32

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

an image of dotted line Image

N/A

5Y Average EV/EBITDA

-0.64

Current EV/EBITDA

-2.58

Overvalued EV/EBITDA

0.38

Undervalued EV/EBITDA

-1.67

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PS

9.11

Current PS

9.71

Overvalued PS

24.83

Undervalued PS

-6.61

Financials

AI Analysis

Annual

Quarterly

Whales Holding SINT

Trading Trends

People Also Watch

Frequently Asked Questions

What is SINTX Technologies Inc (SINT) stock price today?

The current price of SINT is 3.24 USD — it has decreased -2.41 % in the last trading day.

What is SINTX Technologies Inc (SINT)'s business?

SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.

What is the price predicton of SINT Stock?

Wall Street analysts forecast SINT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SINT is16.00 USD with a low forecast of 16.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is SINTX Technologies Inc (SINT)'s revenue for the last quarter?

SINTX Technologies Inc revenue for the last quarter amounts to 208.00K USD, decreased -73.97 % YoY.

What is SINTX Technologies Inc (SINT)'s earnings per share (EPS) for the last quarter?

SINTX Technologies Inc. EPS for the last quarter amounts to -3.46 USD, decreased -50.29 % YoY.

How many employees does SINTX Technologies Inc (SINT). have?

SINTX Technologies Inc (SINT) has 20 emplpoyees as of January 30 2026.

What is SINTX Technologies Inc (SINT) market cap?

Today SINT has the market capitalization of 12.00M USD.